Skip to main content
. 2022 Jan 14;407(3):1161–1171. doi: 10.1007/s00423-022-02428-5

Table 3.

Management outcomes following Atamanalp classification for sigmoid volvulus

Group Definition Treatment Mortality (%) Morbidity (%) Recurrence (%)
I A G 0, A 0, ASA I–III Endoscopic decompression 16.7 16.7 50.0
Plus elective surgery 0.0 0.0 0.0
I B G 0, A I or ASA IV–V Endoscopic decompression 90.9 90.0 27.3
Plus elective surgery 0.0 45.5 0.0
II A G 0, A 0, ASA I–III, E I Urgent surgery 0.0 33.3 0.0
II B G 0, A I or ASA IV–V, E I Urgent surgery 42.9 85.7 0.0
III A G I, A 0, ASA I–III Urgent surgery and stoma 0.0 0.0 0.0
III B G I, A I or ASA IV–V Urgent surgery and stoma 33.3 83.3 0.0

A 0, age < 75 years; A I, age ≥ 75 years; ASA I, patient with no other disease; ASA II, presence of mild systemic disease; ASA III, presence of severe systemic disease; ASA IV, presence of life-threatening systemic disease; ASA V, moribund patient; E I, unsuccessful endoscopy; G 0, no sigmoid gangrene; G I, presence of sigmoid gangrene